Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control

Jose S. Pulido, Sophie J. Bakri, Tibor Valyi-Nagy, Deepak Shukla

Research output: Contribution to journalArticle

23 Scopus citations

Abstract

PURPOSE: To assess whether intravitreal rituximab 1 mg/0.1 cc penetrates the retina of Dutch-belted rabbits. METHODS: Two right eyes of two rabbits were injected with intravitreal rituximab 1 mg/0.1 mL, and one right eye of one rabbit was injected with intravitreal tissue plasminogen activator (tPA) 12.5 μg/0.1 mL, as a protein control. The three left eyes received no intravitreal injections. The rabbits were killed; the eyes were enucleated and immediately frozen at -80°C. Rituximab was detected using rabbit antihuman IgG (whole molecule) peroxidase conjugated antibody. tPA was detected using an antihuman IgG with a sheep antihuman tPA antibody conjugated with peroxidase. RESULTS: There was staining in all retinal layers of the two eyes injected with intravitreal rituximab, and no staining of the retina in the eye injected with intravitreal tPA. The three control eyes showed no staining in any retinal layer. CONCLUSION: Intravitreal rituximab at a dose of 1 mg/0.1 cc penetrates the retina of Dutch-belted rabbits while the control intravitreal tPA at a dose of 12.5 μg/0.1 cc does not.

Original languageEnglish (US)
Pages (from-to)1071-1073
Number of pages3
JournalRetina
Volume27
Issue number8
DOIs
StatePublished - Oct 1 2007

Keywords

  • Alteplase
  • Eye
  • Intravitreal
  • Penetration
  • Retina
  • Rituxan
  • Rituximab
  • Tissue plasminogen activator

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control'. Together they form a unique fingerprint.

  • Cite this